» Articles » PMID: 35511085

Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries

Abstract

Context: The oocyte-secreted factors growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) play essential roles in follicle development and oocyte maturation, and aberrant regulation might contribute to the pathogenesis of polycystic ovary syndrome.

Objective: Are there measurable differences in concentrations of GDF9, BMP15, and the GDF9/BMP15 heterodimer in small antral follicle fluids from women with and without polycystic ovaries (PCO)?

Design And Setting: Follicle fluids (n = 356) were collected from 4- to 11-mm follicles in unstimulated ovaries of 87 women undergoing ovarian tissue cryopreservation for fertility preservation.

Patients: Twenty-seven women with PCO were identified and 60 women without PCO-like characteristics (non-PCO women) were matched according to age and follicle size.

Main Outcome Measures: Intrafollicular concentrations of GDF9, BMP15, GDF9/BMP15 heterodimer, anti-Mullerian hormone (AMH), inhibin-A and -B, total inhibin, activin-B and -AB, and follistatin were measured using enzyme-linked immunosorbent assays.

Results: The detectability of GDF9, BMP15, and the GDF9/BMP15 heterodimer were 100%, 94.4%, and 91.5%, respectively, and concentrations were significantly negatively correlated with increasing follicle size (P < 0.0001). GDF9 was significantly higher in women with PCO (PCO: 4230 ± 189 pg/mL [mean ± SEM], n = 188; non-PCO: 3498 ± 199 pg/mL, n = 168; P < 0.03), whereas BMP15 was lower in women with PCO (PCO: 431 ± 40 pg/mL, n = 125; non-PCO: 573 ± 55 pg/mL, n = 109; P = 0.10), leading to a significantly higher GDF9:BMP15 ratio in women with PCO (P < 0.01). Significant positive associations between BMP15 and AMH, activins, and inhibins in non-PCO women switched to negative associations in women with PCO.

Conclusions: Intrafollicular concentrations of GDF9 and BMP15 varied inversely in women with PCO reflecting an aberrant endocrine environment. An increased GDF9:BMP15 ratio may be a new biomarker for PCO.

Citing Articles

Unraveling the complexity of follicular fluid: insights into its composition, function, and clinical implications.

Pan Y, Pan C, Zhang C J Ovarian Res. 2024; 17(1):237.

PMID: 39593094 PMC: 11590415. DOI: 10.1186/s13048-024-01551-9.


Competence of Combined Low Dose of Human Chorionic Gonadotropin (HCG) and Clomiphene Citrate (CC) Versus Continued CC during Ovulation Induction in Women with CC-Resistant Polycystic Ovarian Syndrome: A Randomized Controlled Trial.

Thabet M, Abdelhafez M, Elshamy M, Albahlol I, Fayala E, Wageeh A Medicina (Kaunas). 2024; 60(8).

PMID: 39202581 PMC: 11356540. DOI: 10.3390/medicina60081300.


The Differentiation Fate of Granulosa Cells and the Regulatory Mechanism in Ovary.

Chen Y, Wang S, Zhang C Reprod Sci. 2024; .

PMID: 39192066 DOI: 10.1007/s43032-024-01682-w.


Comparative Analysis of the Ovary Transcriptome among Wanyue Black and Yorkshire Gilts Using RNA-Seq.

Zhang H, Chen S, Liu Y, Xie F, Wen H, Zhao S Vet Sci. 2024; 11(3).

PMID: 38535849 PMC: 10975710. DOI: 10.3390/vetsci11030115.


A rare germline BMP15 missense mutation causes hereditary ovarian immature teratoma in human.

Liu Y, Fan H, Kang X, Hao Y, Wang N, Zheng H Proc Natl Acad Sci U S A. 2024; 121(10):e2310409121.

PMID: 38427603 PMC: 10927523. DOI: 10.1073/pnas.2310409121.


References
1.
Belli M, Shimasaki S . Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function. Vitam Horm. 2018; 107:317-348. PMC: 6309678. DOI: 10.1016/bs.vh.2017.12.003. View

2.
Yan C, Wang P, DeMayo J, Demayo F, Elvin J, Carino C . Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001; 15(6):854-66. DOI: 10.1210/mend.15.6.0662. View

3.
Roy S, Gandra D, Seger C, Biswas A, Kushnir V, Gleicher N . Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells. Endocrinology. 2018; 159(9):3433-3445. PMC: 6112599. DOI: 10.1210/en.2018-00609. View

4.
Karagul M, Aktas S, Coskun Yilmaz B, Yilmaz M, Temel G . GDF9 and BMP15 Expressions and Fine Structure Changes During Folliculogenesis in Polycystic Ovary Syndrome. Balkan Med J. 2017; 35(1):43-54. PMC: 5820447. DOI: 10.4274/balkanmedj.2016.1110. View

5.
Takebayashi K, Takakura K, Wang H, Kimura F, Kasahara K, Noda Y . Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril. 2000; 74(5):976-9. DOI: 10.1016/s0015-0282(00)01539-9. View